The FDA keeps breaking its word to dying patients

For the past year, the Food and Drug Administration has done the exact opposite of what it promised. Leaders pledged to accelerate innovation and speed access to treatments for rare diseases. That does not mean abandoning safety guardrails. It means applying those guardrails consistently and without unnecessary delay. Instead, the FDA broke written agreements, reversed…